Search

everythinglearnresearchcommunity

for

Search:↓

JAM-A modification speeds up skin wound healing by boosting fibroblast growth.

Advanced imaging methods have improved understanding of cancer cell interactions and treatment strategies.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

High-dose methotrexate can cause severe skin and nail issues.

The article concludes that proper injection techniques and patient education can prevent serious skin reactions from multiple sclerosis medications.

Flow cytometry was effective in diagnosing metastatic breast cancer in a bone marrow sample.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Avian yolk antibodies offer a promising, ethical alternative for disease prevention and therapy.

Intravenous calcium therapy is a safe and effective treatment for a rare type of rickets.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

CS12192 effectively treats alopecia areata with better safety than current options.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

KIT's role in skin cells is not entirely independent, as other cells can influence its function.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.